Synthetic organic

EB-42486.

EB-42486.

ebaresdax.

ebaresdax.

InformationEBI-2511 EBI-2511 is a highly potent and orally active EZH2 inhibitor with an IC50 of 4 nM for EZH2(A667G).TargetsEZH2(A667G) (Cell-free assay) 4 nMIn vivoIn in vivo experiments, rats are administrated with dosages of 5 mg/kg EBI-2511

InformationEBI-2511 EBI-2511 is a highly potent and orally active EZH2 inhibitor with an IC50 of 4 nM for EZH2(A667G).TargetsEZH2(A667G) (Cell-free assay) 4 nMIn vivoIn in vivo experiments, rats are administrated with dosages of 5 mg/kg EBI-2511

InformationEBI-2511 EBI-2511 is a highly potent and orally active EZH2 inhibitor with an IC50 of 4 nM for EZH2(A667G).TargetsEZH2(A667G) (Cell-free assay) 4 nMIn vivoIn in vivo experiments, rats are administrated with dosages of 5 mg/kg EBI-2511

InformationEBI-2511 EBI-2511 is a highly potent and orally active EZH2 inhibitor with an IC50 of 4 nM for EZH2(A667G).TargetsEZH2(A667G) (Cell-free assay) 4 nMIn vivoIn in vivo experiments, rats are administrated with dosages of 5 mg/kg EBI-2511

InformationEBI-2511 EBI-2511 is a highly potent and orally active EZH2 inhibitor with an IC50 of 4 nM for EZH2(A667G).TargetsEZH2(A667G) (Cell-free assay) 4 nMIn vivoIn in vivo experiments, rats are administrated with dosages of 5 mg/kg EBI-2511

InformationEBI-2511 EBI-2511 is a highly potent and orally active EZH2 inhibitor with an IC50 of 4 nM for EZH2(A667G).TargetsEZH2(A667G) (Cell-free assay) 4 nMIn vivoIn in vivo experiments, rats are administrated with dosages of 5 mg/kg EBI-2511

InformationEBI-2511 EBI-2511 is a highly potent and orally active EZH2 inhibitor with an IC50 of 4 nM for EZH2(A667G).TargetsEZH2(A667G) (Cell-free assay) 4 nMIn vivoIn in vivo experiments, rats are administrated with dosages of 5 mg/kg EBI-2511

Ebselen is an interesting organoselenium compound displaying antiinflammatory and antioxidant properties. Ebselen is shown to inhibit the 5-lipoxygenase (5-LO) and 15-lipoxygenase (15-LO) enzymes in the absence of glutathione. Ebselen also inhibits